T. Rowe Price Associates’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Buy |
1,471,223
+1,210,181
| +464% | +$13.6M | ﹤0.01% | 998 |
|
|
2025
Q1 | $2.63M | Buy |
261,042
+12,778
| +5% | +$129K | ﹤0.01% | 1490 |
|
|
2024
Q4 | $2.94M | Sell |
248,264
-25,367
| -9% | -$300K | ﹤0.01% | 1462 |
|
|
2024
Q3 | $3.16M | Buy |
273,631
+26,407
| +11% | +$305K | ﹤0.01% | 1436 |
|
|
2024
Q2 | $2.61M | Sell |
247,224
-353,645
| -59% | -$3.74M | ﹤0.01% | 1444 |
|
|
2024
Q1 | $6.33M | Sell |
600,869
-3,185,744
| -84% | -$33.6M | ﹤0.01% | 1174 |
|
|
2023
Q4 | $42.5M | Buy |
3,786,613
+74,131
| +2% | +$832K | 0.01% | 751 |
|
|
2023
Q3 | $43.4M | Buy |
3,712,482
+3,662,354
| +7,306% | +$42.8M | 0.01% | 728 |
|
|
2023
Q2 | $506K | Buy |
+50,128
| New | +$506K | ﹤0.01% | 2120 |
|